Ligand validation:2Q80

GRG: GERANYLGERANYL DIPHOSPHATE

GRG is a Ligand Of Interest in 2Q80 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2Q80_GRG_D_500	78%	17%	0.114	0.956	2.38	1.25	13	5	2	0	100%	1
2Q80_GRG_A_500	76%	18%	0.115	0.951	2.17	1.41	12	5	2	0	100%	1
2Q80_GRG_B_500	74%	17%	0.122	0.951	2.31	1.33	12	4	0	0	100%	1
2Q80_GRG_E_500	63%	19%	0.143	0.94	2.17	1.29	10	5	3	0	100%	1
2Q80_GRG_C_500	61%	18%	0.139	0.928	2.25	1.3	9	6	2	0	100%	1
2Q80_GRG_F_500	45%	17%	0.14	0.932	2.44	1.24	7	2	4	0	66%	1
9HJS_GRG_D_401	84%	30%	0.107	0.968	1.22	1.57	1	7	7	0	100%	1
4OPD_GRG_B_502	99%	42%	0.047	0.987	0.67	1.57	-	6	6	0	100%	0.9
2E8V_GRG_B_1502	86%	26%	0.088	0.957	1.84	1.18	8	5	0	0	100%	1
3PZ2_GRG_B_334	78%	16%	0.138	0.981	2.09	1.65	11	5	2	0	100%	1
1N4S_GRG_J_1505	76%	57%	0.12	0.958	0.77	0.89	-	1	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.